Filing Details

Accession Number:
0000914190-13-000819
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-12 16:11:14
Reporting Period:
2013-11-07
Filing Date:
2013-11-12
Accepted Time:
2013-11-12 16:11:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180145 Cardiovascular Systems Inc CSII Surgical & Medical Instruments & Apparatus (3841) 411698056
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1067915 H John Friedman 651 Campus Drive
St. Paul MN 55112
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-11-07 151,617 $8.83 572,640 No 4 X Indirect Easton Capital Partners, LP
Common Stock Disposition 2013-11-07 45,065 $29.71 527,575 No 4 S Indirect Easton Capital Partners, LP
Common Stock Acquisiton 2013-11-07 151,617 $8.83 211,177 No 4 X Indirect Easton Hunt Capital Partners, L.P.
Common Stock Disposition 2013-11-07 45,065 $29.71 166,112 No 4 S Indirect Easton Hunt Capital Partners, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Indirect Easton Capital Partners, LP
No 4 S Indirect Easton Capital Partners, LP
No 4 X Indirect Easton Hunt Capital Partners, L.P.
No 4 S Indirect Easton Hunt Capital Partners, L.P.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (Right to Buy) Disposition 2013-11-07 151,617 $0.00 151,617 $8.83
Common Stock Warrant (Right to Buy) Disposition 2013-11-07 151,617 $0.00 151,617 $8.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-02-25 2014-02-24 No 4 X Indirect
0 2009-02-25 2014-02-24 No 4 X Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,000 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $7.90 2017-10-08 4,321 4,321 Direct
Common Stock Stock Option (right to buy) $11.38 2017-11-12 15,088 15,088 Direct
Common Stock Stock Option (right to buy) $8.83 2016-08-14 38,820 38,820 Direct
Common Stock Restricted Stock Units $0.00 5,714 5,714 Direct
Common Stock Restricted Stock Units $0.00 11,628 11,628 Direct
Common Stock Restricted Stock Units $0.00 21,739 21,739 Direct
Common Stock Restricted Stock Units $0.00 7,192 7,192 Direct
Common Stock Restricted Stock Units $0.00 10,917 10,917 Direct
Common Stock Restricted Stock Units $0.00 4,580 4,580 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2017-10-08 4,321 4,321 Direct
2017-11-12 15,088 15,088 Direct
2016-08-14 38,820 38,820 Direct
5,714 5,714 Direct
11,628 11,628 Direct
21,739 21,739 Direct
7,192 7,192 Direct
10,917 10,917 Direct
4,580 4,580 Direct
Footnotes
  1. Mr. Friedman disclaims beneficial ownership of shares held by Easton Capital Partners, LP except to the extent of his pecuniary interest therein.
  2. On November 7, 2013, the reporting person exercised two warrants, each to purchase 151,617 shares of Cardiovascular Systems, Inc. ("CSI") common stock for $8.83 a share. The reporting person paid the exercise price for each warrant on a cashless basis, resulting in CSI's withholding of 45,065 of the warrant shares of each warrant to pay the exercise price and issuing to the reporting person the remaining 106,552 shares of each warrant.
  3. Mr. Friedman disclaims beneficial ownership of shares held by Easton Hunt Capital Partners, L.P. except to the extent of his pecuniary interest therein.
  4. Fully exercisable.
  5. Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of the Company's Common Stock beginning six months following the termination of each director's board membership.
  6. Mr. Friedman disclaims beneficial ownership of warrants held by Easton Hunt Capital Partners, L.P. and Easton Capital Partners, LP except to the extent of his pecuniary interest therein.